Boston University Medical Campus
Pulmonary, Critical Care, and Allergy Medicine

Internship:

• COPD
• Pulmonary Rehabilitation
• Molecular Biology of Lung Cancer (conducted in fellowship)

CLINICAL:

• General Pulmonary Medicine: evaluation of dyspnea, cardiopulmonary disease, COPD, obesity-related lung disease
• Procedural aspects of Pulmonary/Critical Care
• Critical Care Medicine
• Pulmonary Rehabilitation

Dr. Sloan attends on inpatient pulmonary and critical care services at Boston Medical Center and she sees patients in the outpatient Pulmonary Clinic. She is also Medical Director of the Pulmonary Rehabilitation program.

Selected Publications:

1. K.A Sloan, H.A. Marquez, J. Li, Y. Cao, A. Hinds, C.J. O’Hara, S. Kathuria, M.I. Ramirez, M.C. Williams, and H. Kathuria. Increased PEA3/E1AF and Decreased Net/Elk-3, both Ets Proteins, Characterize Human NSCLC Progression and Regulate Caveolin-1 Transcription in Calu-1 and NCI-H23 NSCLC Cell Lines. Carcinogenesis. 2009 May 29. [Epub ahead of print].
2. K.A. Sloan, Y.X. Cao, MD , A. Hinds, S. Kathuria, MD, M.C. Williams, PhD, and H. Kathuria, MD. Transcriptional Regulation of Caveolin-1 by the ETS protein NET/ELK-3 in Non-Small Cell Lung Cancer Cell Lines. American Journal of Respiratory and Critical Care Medicine April 2008; 177: A932.
3. K.A. Sloan, MD, A. Hinds, B. Akkanti, MD, M.C. Williams, PhD, and H. Kathuria, MD. Changes in Caveolin-1 Expression as a Function of Human Lung Adenocarcinoma Progression. American Journal of Respiratory and Critical Care Medicine April 2007 Abstract.
4. Peter S. Marshall, MD, Mark Siegel, MD, Kevin Johnson, MD, Karin Kelley, MD [maiden name] , Bianca Monteiro, MD and Yoel Vivas, MD. Computed Tomography Can Predict Adverse Outcomes in Patients Presenting with Pulmonary Embolus. Chest 2005; 128(4): 199-200S.

Links:
Pulmonary Rehabilitation at Boston Medical Center

Dr. Sloan sees patients in the following locations:
DOB